CARIS CHROMOSEQ Trademark
Trademark Overview
On Friday, October 10, 2025, a trademark application was filed for CARIS CHROMOSEQ with the United States Patent and Trademark Office. The USPTO has given the CARIS CHROMOSEQ trademark a serial number of 99437005. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 2, 2026. This trademark is owned by Caris MPI, Inc.. The CARIS CHROMOSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies
Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, conducting whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies for others
General Information
| Serial Number | 99437005 |
| Word Mark | CARIS CHROMOSEQ |
| Filing Date | Friday, October 10, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 2, 2026 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies |
| Description of Mark | The mark consists of three concentric arches. Below the arches is the stylized text, "CARIS CHROMOSEQ". The stylized letter "A" in "CARIS" is presented without the middle connecting line. |
| Goods and Services | Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, conducting whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies for others |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 10, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Caris MPI, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irving, TX 75039
US |
| Party Name | Caris MPI, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irving, TX 75039
US |
Trademark Events
| Event Date | Event Description |
| Friday, October 10, 2025 | NEW APPLICATION ENTERED |
| Friday, October 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 26, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 26, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, February 27, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 9, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 9, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 9, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 3, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 3, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 3, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 5, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 27, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 2, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 2, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
